View in EDS

Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials.

Saved in:
Bibliographic Details
Title: Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials.
Authors: Bouxsein ML (AUTHOR), Chen P (AUTHOR), Glass EV (AUTHOR), Kallmes DF (AUTHOR), Delmas PD (AUTHOR), Mitlak BH (AUTHOR), Bouxsein, Mary L1 (AUTHOR), Chen, Peiqi (AUTHOR), Glass, Emmett V (AUTHOR), Kallmes, David F (AUTHOR), Delmas, Pierre D (AUTHOR), Mitlak, Bruce H (AUTHOR)
Source: Journal of Bone & Joint Surgery, American Volume. Jun2009, Vol. 91 Issue 6, p1329-1338.
Database: SPORTDiscus with Full Text
Description
ISSN:00219355
DOI:10.2106/JBJS.H.01030